NICE has recommended natalizumab for adults with highly active RRMS, citing pregnancy suitability, biosimilar value and NHS ...

Atacicept, a novel dual inhibitor of BAFF and APRIL, receives FDA Priority Review for IgA nephropathy treatment in adults.

A phase 1 study to evaluate safety, tolerability, bioavailability, pharmacokinetics, and weight loss of GLP-1/GLP-2 dual ...

If approved, lecanemab may become the first and only anti-amyloid treatment in China to offer an at-home injection from the ...

Senate Bill 11 was introduced as lethal injection drugs have become more expensive and hard to get, leading some states to ...

Specialty Vehicle Engineering has announced a new, more-extreme addition to the Yenko performance heritage with the debut of ...

The Senate Corrections and Criminal Law committee discussed a bill Tuesday that would allow firing squad executions for death ...

A researcher is planning on investigating potential treatments aimed at the root causes of type 1 diabetes. At the (MUSC), ...

BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that the Biologics License Application (BLA) for the subcutaneous formulation ...

The Auburn Tigers are pushing to earn a commitment from former Georgia and Purdue wide receiver Nitro Tuggle. Tuggle spent ...

The U.S. is cutting the Hepatitis B vaccine from its recommended list. But here's a place where the medical establishment — ...

Lunsumio Velo is supplied as a ready-to-use, preservative-free solution in single-dose vials containing 5mg/0.5mL and 45mg/mL.